NEXGEL, Inc.
General ticker "NXGL" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $19.9M (TTM average)
NEXGEL, Inc. does not follow the US Stock Market performance with the rate: -19.9%.
Estimated limits based on current volatility of 8.1%: low 0.60$, high 0.70$
Factors to consider:
- Total employees count: 6 as of 2019
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Market acceptance, Supply chain disruptions, Market competition, Regulatory and compliance, Product liability
- Current price 40.3% below estimated low
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.06$, 2.29$]
- 2026-12-31 to 2027-12-31 estimated range: [1.06$, 2.24$]
Financial Metrics affecting the NXGL estimates:
- Positive: with PPE of -4.2 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -10.39 <= 0.07
- Positive: 42.60 < Shareholder equity ratio, % of 42.62 <= 64.25
- Positive: Inventory ratio change, % of 0.27 <= 0.80
- Positive: Investing cash flow per share per price, % of -0.54 > -0.65
- Positive: Return on assets ratio (scaled to [-100,100]) of 21.66 > 6.12
- Positive: Interest expense per share per price, % of 0.27 <= 0.73
Short-term NXGL quotes
Long-term NXGL plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $4.09MM | $8.69MM | $11.42MM |
| Operating Expenses | $7.57MM | $12.24MM | $14.77MM |
| Operating Income | $-3.48MM | $-3.55MM | $-3.35MM |
| Non-Operating Income | $0.29MM | $0.09MM | $0.46MM |
| Interest Expense | $0.01MM | $0.08MM | $0.03MM |
| R&D Expense | $0.10MM | $0.08MM | $0.00MM |
| Income(Loss) | $-3.19MM | $-3.46MM | $-2.89MM |
| Profit(Loss)* | $-3.16MM | $-3.28MM | $-3.00MM |
| Stockholders Equity | $4.70MM | $5.75MM | $4.46MM |
| Inventory | $1.32MM | $1.75MM | $2.11MM |
| Assets | $9.96MM | $10.98MM | $10.46MM |
| Operating Cash Flow | $-3.24MM | $-3.87MM | $-1.31MM |
| Capital expenditure | $0.70MM | $0.44MM | $0.07MM |
| Investing Cash Flow | $4.46MM | $-0.78MM | $-0.07MM |
| Financing Cash Flow | $0.38MM | $3.75MM | $0.63MM |
| Earnings Per Share** | $-0.56 | $-0.50 | $-0.38 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.